Clin2
NCT07847580Possibly a fitNot yet recruiting

Nasal sedative for heart protection during coronary stent procedure

Coronary Heart DiseaseCoronary Artery Disease

Treatments studied

Part of Heart & circulation clinical trials.

This study tests whether a sedative given as a nasal spray (called dexmedetomidine) can help protect your heart during a planned procedure to open blocked heart arteries. If you are having this procedure, the medication may reduce the risk of heart damage afterward.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
2,500 people
Ages
45 years to 85 years
Study type
Interventional

Who can take part

  • You are between 45 and 85 years old.
  • You have coronary artery disease (blocked heart arteries) and are scheduled for a planned procedure to open those blockages (called a percutaneous coronary intervention, or PCI).
  • You do not have certain heart rhythm problems like a very slow heartbeat or certain heart blocks that would make the study drug unsafe.
  • Your heart is pumping well enough (with an ejection fraction of 40% or higher) and you are not in severe heart failure.
  • You do not have sleep apnea or a body mass index (BMI) over 30.
  • You are not pregnant or nursing, and you have no severe liver or kidney problems.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07549282Not yet recruiting· Phase 4
Nasal sedative to protect the heart during angioplasty

This study tests whether a sedative given as a nasal spray before a heart procedure (angioplasty) can reduce heart damage. It may help people with heart disease who are having this procedure.

Hangzhou, Zhejiang
NCT04912518Recruiting
Dexmedetomidine for heart protection after a specific heart attack

This study tests whether dexmedetomidine can protect the heart in people who are having a specific type of heart attack (anterior STEMI) when treated within 6 hours of symptom start. You may be considered if your diagnosis and vital signs fit the study safety rules, and if you can take part in follow-up.

Hefei, Anhui
NCT07298525Not yet recruiting· Phase 4
Comfort before anesthesia with a nasal spray

This trial tests a nasal spray that helps you feel calm and relaxed before anesthesia for your surgery. It may be an option for people having general anesthesia or other types of anesthesia, and the study checks if it is safe and works well.

NCT07801014Not yet recruiting
Calming nasal spray for anxiety before brain surgery

This trial tests whether a nasal spray with a calming medicine (dexmedetomidine) can reduce anxiety before brain surgery. It is given before the operation to help you feel more relaxed and calm.

Beijing, Beijing Municipality
NCT07611890Recruiting· Phase 4
Comparing two medications to reduce heart stress during cardiac surgery

This trial tests whether dexmedetomidine or lignocaine better prevents dangerous heart-rate and blood-pressure changes when a breathing tube is placed during heart surgery. If you're having cardiac surgery and are at high risk for heart complications, this study may help protect your heart during the procedure.

Rawalpindi, Punjab Province
NCT07080229Recruiting· Phase 3
Nasal spray for blood pressure during cataract surgery in older adults

This trial tests whether a nasal spray of dexmedetomidine can help control blood pressure in older adults with high blood pressure who are having cataract surgery. It may keep your blood pressure more stable during the procedure.

Ismailia, Ismailia Governorate

Hear when a new Coronary Heart Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.